Analysis of Gene Expression Using Gene Sets Discriminates Cancer Patients with and without Late Radiation Toxicity
暂无分享,去创建一个
Harry Vrieling | Micheline Giphart-Gassler | J. Haveman | M. Giphart-Gassler | L. Stalpers | J. Svensson | H. Vrieling | I. Turesson | N. Franken | J. Peter Svensson | Ingela Turesson | R. Lange | B. Klein | Lukas J. A Stalpers | Rebecca E. E. Esveldt–van Lange | Nicolaas A. P Franken | Jaap Haveman | Binie Klein | N. A. Franken
[1] Alexandra L Hanlon,et al. Dose response in prostate cancer with 8-12 years' follow-up. , 2001, International journal of radiation oncology, biology, physics.
[2] Kathleen F. Kerr,et al. Standardizing global gene expression analysis between laboratories and across platforms , 2005, Nature Methods.
[3] D. Koller,et al. A module map showing conditional activity of expression modules in cancer , 2004, Nature Genetics.
[4] George Starkschall,et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. , 2002, International journal of radiation oncology, biology, physics.
[5] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[6] V. Cheung,et al. Transcriptional response of lymphoblastoid cells to ionizing radiation. , 2003, Genome research.
[7] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[8] J Nyman,et al. Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International Journal of Radiation Oncology, Biology, Physics.
[9] Kenneth H Buetow,et al. Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarrays. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] J. Hopfield,et al. From molecular to modular cell biology , 1999, Nature.
[11] Dauid F. Percy. Cluster Analysis (3rd Edition) , 1994 .
[12] Trey Ideker,et al. Damage recovery pathways in Saccharomyces cerevisiae revealed by genomic phenotyping and interactome mapping. , 2002, Molecular cancer research : MCR.
[13] A. Begg,et al. Editorial radiotherapy and oncology 2002: predictive assays for normal tissue damage. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] J. Peacock,et al. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. , 2003, International journal of radiation oncology, biology, physics.
[15] E. Dikomey,et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] R. Westendorp,et al. Lymphocyte Count and Mortality Risk in Older Persons. The Leiden 85‐Plus Study , 2003, Journal of the American Geriatrics Society.
[17] H. Bartelink,et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. , 1995, International journal of radiation oncology, biology, physics.
[18] Harry Vrieling,et al. Dissecting systems-wide data using mixture models: application to identify affected cellular processes , 2005, BMC Bioinformatics.
[19] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] C. Molony,et al. Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.
[21] R. Tibshirani,et al. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[22] J. Dahm-Daphi,et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] A. Kiltie,et al. Detection of Individual Differences in Radiation-Induced Apoptosis of Peripheral Blood Lymphocytes in Normal Individuals, Ataxia Telangiectasia Homozygotes and Heterozygotes, and Breast Cancer Patients after Radiotherapy , 2000, Radiation research.
[24] Thomas J. Begley,et al. Global network analysis of phenotypic effects: Protein networks and toxicity modulation in Saccharomyces cerevisiae , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] C C Ling,et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. , 2001, The Journal of urology.
[27] Sally A. Amundson,et al. Identification of Potential mRNA Biomarkers in Peripheral Blood Lymphocytes for Human Exposure to Ionizing Radiation , 2000, Radiation research.
[28] P. Koper,et al. Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. , 2005, International journal of radiation oncology, biology, physics.
[29] Jacques Bernier,et al. Late effects toxicity scoring: the SOMA scale , 1995 .
[30] Michael Baumann,et al. Towards genetic prediction of radiation responses: ESTRO's GENEPI project. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] A. Levine,et al. A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans , 2004, Cell.
[32] Gilbert Chu,et al. Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells. , 2004, Nucleic acids research.
[33] Anders Brahme,et al. Biological Response to Radiation Therapy , 2003, Acta oncologica.
[34] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[35] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[36] Tung‐Kwang Lee,et al. Lymphocyte radiosensitivity correlated with pelvic radiotherapy morbidity. , 2002, International journal of radiation oncology, biology, physics.
[37] R. Wurm,et al. Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity , 1992, The Lancet.
[38] A. Zwinderman,et al. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. , 1991, Mutation research.
[39] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[40] J. Ioannidis. Microarrays and molecular research: noise discovery? , 2005, The Lancet.
[41] J. Hendry,et al. Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. , 2002, International journal of radiation oncology, biology, physics.
[42] B. Weir,et al. A systematic statistical linear modeling approach to oligonucleotide array experiments. , 2002, Mathematical biosciences.
[43] H D Thames,et al. Evidence for individual differences in the radiosensitivity of human skin. , 1992, European journal of cancer.
[44] Hunter B. Fraser,et al. Modularity and evolutionary constraint on proteins , 2005, Nature Genetics.
[45] A. Barabasi,et al. Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.